BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15100291)

  • 1. Cathepsin G, and not the asparagine-specific endoprotease, controls the processing of myelin basic protein in lysosomes from human B lymphocytes.
    Burster T; Beck A; Tolosa E; Marin-Esteban V; Rötzschke O; Falk K; Lautwein A; Reich M; Brandenburg J; Schwarz G; Wiendl H; Melms A; Lehmann R; Stevanovic S; Kalbacher H; Driessen C
    J Immunol; 2004 May; 172(9):5495-503. PubMed ID: 15100291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma regulates cathepsin G activity in microglia-derived lysosomes and controls the proteolytic processing of myelin basic protein in vitro.
    Burster T; Beck A; Poeschel S; Øren A; Baechle D; Reich M; Roetzschke O; Falk K; Boehm BO; Youssef S; Kalbacher H; Overkleeft H; Tolosa E; Driessen C
    Immunology; 2007 May; 121(1):82-93. PubMed ID: 17302735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro.
    Beck H; Schwarz G; Schröter CJ; Deeg M; Baier D; Stevanovic S; Weber E; Driessen C; Kalbacher H
    Eur J Immunol; 2001 Dec; 31(12):3726-36. PubMed ID: 11745393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Asparagine endopeptidase is not essential for class II MHC antigen presentation but is required for processing of cathepsin L in mice.
    Maehr R; Hang HC; Mintern JD; Kim YM; Cuvillier A; Nishimura M; Yamada K; Shirahama-Noda K; Hara-Nishimura I; Ploegh HL
    J Immunol; 2005 Jun; 174(11):7066-74. PubMed ID: 15905550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invariant chain processing is independent of cathepsin variation between primary human B cells/dendritic cells and B-lymphoblastoid cells.
    Reich M; Zou F; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
    Cell Immunol; 2011; 269(2):96-103. PubMed ID: 21543057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cathepsin G is differentially expressed in primary human antigen-presenting cells.
    Stoeckle C; Sommandas V; Adamopoulou E; Belisle K; Schiekofer S; Melms A; Weber E; Driessen C; Boehm BO; Tolosa E; Burster T
    Cell Immunol; 2009; 255(1-2):41-5. PubMed ID: 19036358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.
    Burster T; Macmillan H; Hou T; Schilling J; Truong P; Boehm BO; Zou F; Lau K; Strohman M; Schaffert S; Busch R; Mellins ED
    Immunology; 2010 Jul; 130(3):436-46. PubMed ID: 20331476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysosomal cysteine and aspartic proteases are heterogeneously expressed and act redundantly to initiate human invariant chain degradation.
    Costantino CM; Hang HC; Kent SC; Hafler DA; Ploegh HL
    J Immunol; 2008 Mar; 180(5):2876-85. PubMed ID: 18292509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of copolymer 1 and myelin basic protein leads to clustering of class II MHC molecules on antigen-presenting cells.
    Fridkis-Hareli M; Teitelbaum D; Pecht I; Arnon R; Sela M
    Int Immunol; 1997 Jul; 9(7):925-34. PubMed ID: 9237101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential processing of autoantigens in lysosomes from human monocyte-derived and peripheral blood dendritic cells.
    Burster T; Beck A; Tolosa E; Schnorrer P; Weissert R; Reich M; Kraus M; Kalbacher H; Häring HU; Weber E; Overkleeft H; Driessen C
    J Immunol; 2005 Nov; 175(9):5940-9. PubMed ID: 16237087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An asparaginyl endopeptidase processes a microbial antigen for class II MHC presentation.
    Manoury B; Hewitt EW; Morrice N; Dando PM; Barrett AJ; Watts C
    Nature; 1998 Dec; 396(6712):695-9. PubMed ID: 9872320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human B lymphoblastoid cells contain distinct patterns of cathepsin activity in endocytic compartments and regulate MHC class II transport in a cathepsin S-independent manner.
    Lautwein A; Kraus M; Reich M; Burster T; Brandenburg J; Overkleeft HS; Schwarz G; Kammer W; Weber E; Kalbacher H; Nordheim A; Driessen C
    J Leukoc Biol; 2004 May; 75(5):844-55. PubMed ID: 14966190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of legumain.
    Schwarz G; Brandenburg J; Reich M; Burster T; Driessen C; Kalbacher H
    Biol Chem; 2002 Nov; 383(11):1813-6. PubMed ID: 12530547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Destructive processing by asparagine endopeptidase limits presentation of a dominant T cell epitope in MBP.
    Manoury B; Mazzeo D; Fugger L; Viner N; Ponsford M; Streeter H; Mazza G; Wraith DC; Watts C
    Nat Immunol; 2002 Feb; 3(2):169-74. PubMed ID: 11812994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible heat shock protein 70 promotes myelin autoantigen presentation by the HLA class II.
    Mycko MP; Cwiklinska H; Szymanski J; Szymanska B; Kudla G; Kilianek L; Odyniec A; Brosnan CF; Selmaj KW
    J Immunol; 2004 Jan; 172(1):202-13. PubMed ID: 14688327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cathepsin G: roles in antigen presentation and beyond.
    Burster T; Macmillan H; Hou T; Boehm BO; Mellins ED
    Mol Immunol; 2010 Jan; 47(4):658-65. PubMed ID: 19910052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of thiol proteases in tissue injury and remodeling.
    Chapman HA; Munger JS; Shi GP
    Am J Respir Crit Care Med; 1994 Dec; 150(6 Pt 2):S155-9. PubMed ID: 7952652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited proteolysis of myelin basic protein in a system mimetic of the myelin interlamellar aqueous space.
    Nicot C; Vacher M; Denoroy L; Kahn PC; Waks M
    J Neurochem; 1993 Apr; 60(4):1283-91. PubMed ID: 7681099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of specific cell permeable cathepsin G inhibitors resulted in reduced antigen processing in primary dendritic cells.
    Reich M; Lesner A; Legowska A; Sieńczyk M; Oleksyszyn J; Boehm BO; Burster T
    Mol Immunol; 2009 Sep; 46(15):2994-9. PubMed ID: 19615749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.
    Zang YC; Li S; Rivera VM; Hong J; Robinson RR; Breitbach WT; Killian J; Zhang JZ
    J Immunol; 2004 Apr; 172(8):5120-7. PubMed ID: 15067096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.